Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Multicenter, Randomized, Double Blind Study, With Subcutaneous Immunotherapy At Different Doses, in Parallel Groups and Placebo-Controlled, in Patients With Rhinoconjunctivitis ± Asthma Sensitized to Phleum Pratense

NCT01567306 is registered in ClinicalTrials.gov with Roxall Medicina España S.A as lead sponsor.

NCT NCT01567306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01567306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Multicenter, Randomized, Double Blind Study, With Subcutaneous Immunotherapy At Different Doses, in Parallel Groups and Placebo-Controlled, in Patients With Rhinoconjunctivitis ± Asthma Sensitized to Phleum Pratense
Lead sponsor
Roxall Medicina España S.A
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2011
Completion date
April 30, 2013
Enrollment
151 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinoconjunctivitis